| Line item | 2025-09-30 FY | 2024-09-30 FY | 2023-09-30 FY | 2022-09-30 FY | 2021-12-31 FY | 2021-09-30 FY |
|---|---|---|---|---|---|---|
| Revenue | – | – | – | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | $6.41M | $2.78M | $1.44M | $4.06M | $3.10M | $23.82K |
| R&D | $455.90K | $240.26K | $0.00 | $0.00 | $226.45K | – |
| SG&A | – | – | – | – | – | $23.82K |
| Operating Income | -$6.41M | -$2.78M | -$1.44M | -$4.06M | -$3.10M | – |
| Interest Expense | $59.81K | $17.69K | $43.80K | $51.12K | $102.79K | – |
| Tax Expense | – | – | – | $0.00 | $0.00 | – |
| Net Income | -$5.59M | -$2.88M | -$1.71M | -$4.24M | -$3.44M | -$23.82K |
| EPS (basic) | – | -0.1500 | -0.0700 | -0.1300 | -0.1500 | – |
| EPS (diluted) | -0.2200 | -0.1500 | -0.0700 | -0.1300 | -0.1500 | – |
| Shares (diluted) | $25.70M | $19.88M | $19.55M | $32.44M | $22.49M | – |